| 261 |
Soluble tumor necrosis factor-alpha receptors in the serum of endometriosis patients |
2016 |
| 262 |
Soluble tumor necrosis factor-alpha receptors in the serum of endometriosis patients |
2016 |
| 263 |
Staging for low malignant potential ovarian tumors: a global perspective |
2016 |
| 264 |
STEM CELL MARKERS DESCRIBE A TRANSITION FROM SOMATIC TO PLURIPOTENT CELL STATES IN A RAT MODEL OF ENDOMETRIOSIS |
2016 |
| 265 |
Sublingual misoprostol versus intravenous oxytocin in reducing bleeding during and after cesarean delivery: A randomized clinical trial |
2016 |
| 266 |
Sublingual misoprostol versus intravenous oxytocin in reducing bleeding during and after cesarean delivery: A randomized clinical trial |
2016 |
| 267 |
Sublingual misoprostol versus intravenous oxytocin in reducing bleeding during and after cesarean delivery: A randomized clinical trial |
2016 |
| 268 |
Sublingual misoprostol versus intravenous oxytocin in reducing bleeding during and after cesarean delivery: A randomized clinical trial |
2016 |
| 269 |
Sublingual misoprostol versus intravenous oxytocin in reducing bleeding during and after cesarean delivery: A randomized clinical trial |
2016 |
| 270 |
Successful external cephalic version after preterm premature rupture of membranes utilizing amnioinfusion complicated by fetal femoral fracture |
2016 |
Do you have any questions? 
